Last update 20 Mar 2025

MT-0814

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
CCR3
Action
antagonists
Mechanism
CCR3 antagonists(C-C chemokine receptor type 3 antagonists)
Therapeutic Areas
Congenital DisordersEye Diseases
Active Indication
Dystrophy, Macular
Inactive Indication
Age Related Macular DegenerationWet Macular Degeneration
Originator Organization
Mitsubishi Tanabe Pharma Corp.Mitsubishi Tanabe Pharma Corp.
Active Organization
Mitsubishi Tanabe Pharma Corp.Mitsubishi Tanabe Pharma Corp.
Inactive Organization
Senju Pharmaceutical Co., Ltd.
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MT-0814
NCT03869684
/ TerminatedPhase 2
A Double-Masked, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of MT-0814 for the Treatment of Patients With Age-Related Macular Degeneration
100 Clinical Results associated with MT-0814
Login to view more data
100 Translational Medicine associated with MT-0814
Login to view more data
100 Patents (Medical) associated with MT-0814
Login to view more data
100 Deals associated with MT-0814
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Wet Macular DegenerationPhase 2
United States
Mitsubishi Tanabe Pharma Corp.Mitsubishi Tanabe Pharma Corp.
18 Mar 2019
Dystrophy, MacularPhase 2-
Mitsubishi Tanabe Pharma Corp.Mitsubishi Tanabe Pharma Corp.
-
Age Related Macular DegenerationPreclinical
United States
Senju Pharmaceutical Co., Ltd.
25 Feb 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03869684 (CTgov)
Phase 2
Age Related Macular Degeneration
13
Placebo
(Placebo)
lvvhjscnvx(rjxufbqhsx) = rdkwdnnole umnhwiwivw (vegjuvujka, nyxapngpjj - dorhthwwea)
View more
-
20 Apr 2021
Placebo+MT-0814
(MT-0814 Low Dose)
lvvhjscnvx(rjxufbqhsx) = vjqjewrist umnhwiwivw (vegjuvujka, pzgmvqvavb - ommtwtuvdr)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free